Breaking News Instant updates and real-time market news.

NVS

Novartis

$84.01

0.76 (0.91%)

, MNTA

Momenta

$16.30

0.05 (0.31%)

05:21
02/13/18
02/13
05:21
02/13/18
05:21

Sandoz announces FDA approval, launch of Glatopa 40 mg/mL 3 times-a-week option

Sandoz, a Novartis (NVS) division, announced the FDA approval and launch of Glatopa 40 mg/mL. Glatopa 40 mg/mL is FDA-approved as a fully-substitutable, AP-rated generic version of Copaxone 40 mg/mL three times-a-week therapy for relapsing forms of multiple sclerosis, or MS. Glatopa was developed under a collaboration agreement between Momenta Pharmaceuticals (MNTA) and Sandoz and is produced in the U.S.

NVS

Novartis

$84.01

0.76 (0.91%)

MNTA

Momenta

$16.30

0.05 (0.31%)

  • 16

    Feb

  • 21

    Feb

  • 02

    Mar

  • 04

    Apr

  • 23

    Apr

  • 17

    May

NVS Novartis
$84.01

0.76 (0.91%)

01/25/18
CANT
01/25/18
NO CHANGE
Target $105
CANT
Overweight
Cantor reiterates $105 target on Spark Therapeutics after Novartis deal
Cantor Fitzgerald analyst Elemer Piros reiterates an Overweight rating on Spark Therapeutics (ONCE) with a $105 price target after the company announced a licensing and supply agreement with Novartis (NVS). The deal further emphasizes the "significant value" of Luxturna's commercial opportunity, Piros tells investors in a research note. He believes the agreement places the drug with a strong commercial partner outside the U.S. while enabling Spark to remain focused on the domestic launch and development pipeline.
01/25/18
LEER
01/25/18
NO CHANGE
Target $100
LEER
Market Perform
Novartis price target raised to $100 from $93 at Leerink
Leerink analyst Seamus Fernandez raised his price target for Novartis to $100 from $93 following a "strong" quarter and above-consensus 2018 guidance. The analyst reiterates a Market Perform rating on the shares.
02/08/18
RBCM
02/08/18
INITIATION
Target $65
RBCM
Outperform
Spark Therapeutics assumed with an Outperform at RBC Capital
RBC Capital analyst Kennen MacKay assumed coverage of Spark Therapeutics (ONCE) with an Outperform rating and a price target of $65. MacKay says the FDA approval of Luxturna and "ex-Novartis (NVS) collaboration" helps to de-risk the company's earlier-stage hemophilia and inherited retinal disease assets, calling Spark Therapeutics a "trailblazer in the gene therapy space".
02/12/18
LEER
02/12/18
NO CHANGE
Target $502
LEER
Outperform
Data from Regeneron Eylea competitors should lift some overhang, says Leerink
Leerink analyst Geoffrey Porges says that the "confusing and somewhat lackluster data" presented over the weekend for Eylea's theoretical competitors should lift some of the overhang that Regeneron's stock has suffered from over the last 6 months. Novartis' (NVS) brolucizumab pivotal trial is confusing, and the data incomplete, and the analyst has serious doubts about the drug's approvability. Secondly, the addition of Ang2 inhibition to VEGF inhibition, while theoretically intriguing, has so far been of modest benefit despite Roche's (RHHBY) posturing, he contends. Porges reiterates an Outperform rating and $502 price target on Regeneron's shares.
MNTA Momenta
$16.30

0.05 (0.31%)

10/04/17
JPMS
10/04/17
NO CHANGE
JPMS
Overweight
JPMorgan says generic Copaxone approval 'meaninful positive' for Mylan
Mylan's (MYL) generic Copaxone approval, 9-12 months ahead of investor expectations, represents a "meaningful positive" for the story and will "substantially derisk/support" upside to 2017 and 2018 estimates, JPMorgan analyst Chris Schott tells investors in a research note. The analyst reiterates an Overweight rating on the shares. For Teva (TEVA), the approval puts further pressure on the company's "already challenged" near-term earnings profile and delevering efforts, Schott writes. The analyst keeps a Neutral rating on the shares. The analyst believes the earlier than expected approval for Mylan represents a setback for Momenta Pharmaceuticals' (MNTA) generic Copaxone opportunity. Schott had assumed the company's Glatopa would be the first generic version of Copaxone 40mg to enter the market, but he notes the product has been delayed due to manufacturing issues at a Pfizer (PFE) plant handling fill/ for the drug. The analyst, however, continues to see a "large and fairly durable" generic opportunity for Glatopa. He keeps an Overweight rating on Momenta shares, which are down 27% in premarket trading to $12.75. Mylan is up 17% to $38.20 while Teva is down 15% to $15.95.
10/04/17
STFL
10/04/17
DOWNGRADE
STFL
Hold
Momenta downgraded to Hold from Buy at Stifel
10/04/17
10/04/17
DOWNGRADE
Target $15

Hold
Momenta downgraded after Mylan generic Copaxone approval at Stifel
As previously reported, Stifel analyst Thomas Shrader downgraded Momenta (MNTA) to Hold from Buy, saying that Mylan (MYL) receiving FDA approval of its 40 mg/mL and 20 mg/mL generic Copaxone variants is a "clear negative" for Momenta's Glatopa franchise. Based on that news, he has cut his forecast for Glatopa revenue and lowered his price target on Momenta shares to $15 from $22.
10/05/17
GSCO
10/05/17
NO CHANGE
Target $14
GSCO
Neutral
Momenta price target cut to $14 following Mylan gCopaxone approval at Goldman
Goldman analyst Dana Flanders lowered Momenta (MNTA) estimates and cut its price target on share to $14 from $18 following Mylan's (MYL) generic Copaxone approval. The analyst maintained a Neutral rating on Momenta given uncertainties on how the gCopaxone market will play out and lack of near-term pipeline catalysts.

TODAY'S FREE FLY STORIES

MKL

Markel

$1,121.90

14.9 (1.35%)

17:12
02/23/18
02/23
17:12
02/23/18
17:12
Syndicate
Breaking Syndicate news story on Markel »

Markel files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$20.15

0.34 (1.72%)

17:08
02/23/18
02/23
17:08
02/23/18
17:08
Syndicate
Bright Scholar files to sell 10M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$162.09

2.69 (1.69%)

, MYL

Mylan

$41.45

0.17 (0.41%)

17:04
02/23/18
02/23
17:04
02/23/18
17:04
Periodicals
PTAB denies Allergan's bid to dismiss restasis patent challenge, Bloomberg says »

Allergan's (AGN)…

AGN

Allergan

$162.09

2.69 (1.69%)

MYL

Mylan

$41.45

0.17 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 19

    Mar

  • 25

    Mar

  • 23

    Apr

  • 13

    Nov

SCHW

Charles Schwab

$52.74

0.71 (1.36%)

17:03
02/23/18
02/23
17:03
02/23/18
17:03
Hot Stocks
Charles Schwab appoints Joseph Martinetto as COO of the firm »

On February 22, the board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$69.02

1.38 (2.04%)

, BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

17:02
02/23/18
02/23
17:02
02/23/18
17:02
Hot Stocks
Kraft Heinz announces retirement of Warren Buffett from Board of Directors »

The Kraft Heinz Company…

KHC

Kraft Heinz

$69.02

1.38 (2.04%)

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

BUD

AB InBev

$107.25

1.91 (1.81%)

QSR

Restaurant Brands

$59.46

1.02 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 07

    Mar

  • 18

    Mar

SWX

Southwest Gas

$69.17

1.65 (2.44%)

17:02
02/23/18
02/23
17:02
02/23/18
17:02
Hot Stocks
Southwest Gas increases quarterly common stock dividend »

The board for Southwest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

MS

Morgan Stanley

$56.07

1.21 (2.21%)

, AAOI

Applied Optoelectronics

$28.02

0.51 (1.85%)

16:56
02/23/18
02/23
16:56
02/23/18
16:56
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Applied Optoelectronics »

Morgan Stanley reports…

MS

Morgan Stanley

$56.07

1.21 (2.21%)

AAOI

Applied Optoelectronics

$28.02

0.51 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 25

    Feb

  • 12

    Mar

  • 13

    Mar

  • 29

    Mar

HSBC

HSBC

$51.23

0.19 (0.37%)

16:49
02/23/18
02/23
16:49
02/23/18
16:49
Syndicate
Breaking Syndicate news story on HSBC »

HSBC files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

X

U.S. Steel

$43.52

0.54 (1.26%)

, AKS

AK Steel

$5.50

-0.12 (-2.14%)

16:48
02/23/18
02/23
16:48
02/23/18
16:48
Periodicals
Breaking Periodicals news story on U.S. Steel, AK Steel »

Trump said to want 24%…

X

U.S. Steel

$43.52

0.54 (1.26%)

AKS

AK Steel

$5.50

-0.12 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPL

PPL Corp.

$30.34

0.82 (2.78%)

16:36
02/23/18
02/23
16:36
02/23/18
16:36
Syndicate
PPL Corp. files to sell $1B of common stock »

J.P. Morgan Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 16

    May

L

Loews

$50.34

0.74 (1.49%)

16:33
02/23/18
02/23
16:33
02/23/18
16:33
Syndicate
Breaking Syndicate news story on Loews »

Loews files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

GBL

GAMCO Investors

$27.26

1.56 (6.07%)

, CHE

Chemed

$261.22

5.59 (2.19%)

16:31
02/23/18
02/23
16:31
02/23/18
16:31
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, Chemed »

Gabelli reports 4.28%…

GBL

GAMCO Investors

$27.26

1.56 (6.07%)

CHE

Chemed

$261.22

5.59 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
02/23/18
02/23
16:30
02/23/18
16:30
Options
Preliminary option volume of 19.2M today »

Preliminary option volume…

CTO

Consolidated Tomoka

$62.60

0.73 (1.18%)

16:24
02/23/18
02/23
16:24
02/23/18
16:24
Hot Stocks
Consolidated Tomoka acquires net lease property in Aspen, CO for $26.5M »

Consolidated-Tomoka Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

HPE

HP Enterprise

$18.14

1.73 (10.54%)

, HPQ

HP Inc.

$22.13

0.74 (3.46%)

16:21
02/23/18
02/23
16:21
02/23/18
16:21
General news
On The Fly: Top stock stories for Friday »

Stocks opened in positive…

HPE

HP Enterprise

$18.14

1.73 (10.54%)

HPQ

HP Inc.

$22.13

0.74 (3.46%)

BUFF

Blue Buffalo Pet Products

$40.00

5.88 (17.23%)

GIS

General Mills

$52.98

-1.97 (-3.59%)

JWN

Nordstrom

$53.56

3.29 (6.54%)

MOMO

Momo

$35.75

5.22 (17.10%)

TTD

Trade Desk

$59.94

11.54 (23.84%)

KMPH

KemPharm

$6.00

0.738 (14.03%)

GOGO

Gogo

$8.88

-0.25 (-2.74%)

AAL

American Airlines

$53.39

0.41 (0.77%)

OLED

Universal Display

$130.40

-24.5 (-15.82%)

FSLR

First Solar

$61.79

-4.49 (-6.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 01

    Mar

  • 04

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 11

    Mar

  • 12

    Mar

  • 15

    Mar

  • 18

    Mar

  • 24

    Apr

  • 30

    May

VIX

Volatility Index S&P 500 Options

16:20
02/23/18
02/23
16:20
02/23/18
16:20
Options
Closing CBOE SPX and VIX Index summary for February 23rd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEMG

SemGroup

$25.50

1.5 (6.25%)

, VLO

Valero

$92.46

0.41 (0.45%)

16:18
02/23/18
02/23
16:18
02/23/18
16:18
Hot Stocks
SemGroup to sell SemLogistics business unit to Valero »

SemGroup (SEMG) announced…

SEMG

SemGroup

$25.50

1.5 (6.25%)

VLO

Valero

$92.46

0.41 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

$NSD

NASDAQ Market Internals

16:17
02/23/18
02/23
16:17
02/23/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
02/23/18
02/23
16:16
02/23/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

16:11
02/23/18
02/23
16:11
02/23/18
16:11
Hot Stocks
Breaking Hot Stocks news story on Wendy's »

Eminence Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 30

    May

IRIX

IRIDEX

$7.41

0.21 (2.92%)

16:09
02/23/18
02/23
16:09
02/23/18
16:09
Earnings
Breaking Earnings news story on IRIDEX »

IRIDEX sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 11

    Mar

IRIX

IRIDEX

$7.41

0.21 (2.92%)

16:09
02/23/18
02/23
16:09
02/23/18
16:09
Earnings
Breaking Earnings news story on IRIDEX »

IRIDEX sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 11

    Mar

HTZ

Hertz

$20.65

0.085 (0.41%)

, SYMC

Symantec

$27.43

0.45 (1.67%)

16:07
02/23/18
02/23
16:07
02/23/18
16:07
Hot Stocks
Corporate pressure on NRA builds as more companies cut ties »

The National Rifle…

HTZ

Hertz

$20.65

0.085 (0.41%)

SYMC

Symantec

$27.43

0.45 (1.67%)

MET

MetLife

$47.41

0.78 (1.67%)

CB

Chubb

$143.76

0.69 (0.48%)

AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

RGR

Sturm, Ruger

$49.80

0.8 (1.63%)

VSTO

Vista Outdoor

$18.19

-0.23 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 13

    Mar

  • 14

    Mar

  • 12

    Jun

NNA

Navios Acquisition

$0.74

-0.0135 (-1.79%)

16:06
02/23/18
02/23
16:06
02/23/18
16:06
Hot Stocks
Navios Acquisition receives continue listing standards notice from NYSE »

Navios Acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$7.41

0.21 (2.92%)

16:06
02/23/18
02/23
16:06
02/23/18
16:06
Hot Stocks
IRIDEX issues voluntary recall of TruFocus LIO Premiere ophthalmoscope »

On February 23, IRIDEX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 11

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.